The primary interests of our lab are on the immune cell signaling and the balance between T cell tolerance and inflammation. We identified a critical role of deltex1 (DTX1) in T cell tolerance. Dtx1 is a transcription target of NFAT and is up-regulated in T cell anergy. Deficiency of DTX1 augments T cell activation, confers resistance to anergy induction, enhances autoantibody generation, and increases inflammation. Regulatory T cells (Tregs) suppress excess immune cells activation to maintain immune tolerance. We identified a specific role for DTX1 in the maintenance of Foxp3 protein stability and Treg inhibitory activity in vivo; DTX1 protects Foxp3 from HIF-1α-mediated downregulation in inflammatory tissues (A). We also identified another tolerance-associated molecule, death associated protein kinase (DAPK). Deficiency in DAPK leads to preferential differentiation of Th17 cells and development of experimental autoimmune encephalomyelitis. Th17 differentiation is accompanied by DAPK down-regulation and HIF-1α upregulation. In addition, X-linked inhibitor of apoptosis protein (XIAP) is essential in maintaining Tregs stability. Xiap-/- Tregs are prone to IFN-γ secretion and are defective in suppressive function. Xiap-/- Tregs display diminished SOCS1 expression, essential for suppressing inflammatory cytokine signaling (B). The impaired function of Tregs contributes to X-linked lymphoproliferative syndrome type-2. We further identified an unexpected role of HIF-2α for Tregs function. Despite normal development, HIF-2α-KO Tregs lose their in vivo suppressive functions, and are susceptible to reprogramming into IL-17-secreting inflammatory cells. Mice with Treg-conditional KO of HIF-2α are sensitive to inflammatory disease development, yet are resistant to carcinogenesis, illustrating the indispensable role of Tregs in immune tolerance and anticancer activity of the destabilized Tregs (C).